首页> 外文期刊>Journal of psychoactive drugs >A Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Regular Methamphetamine Use in Methadone Treatment
【24h】

A Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Regular Methamphetamine Use in Methadone Treatment

机译:常规甲基苯丙胺用途的随机对照试验在美沙酮治疗中使用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This study evaluated the efficacy of brief cognitive behavioral therapy (BCBT) for regular methamphetamine use among methadone-maintained women. A randomized controlled trial was conducted in four methadone treatment services. Eligible women were assigned to receive either BCBT or drug education. Five questionnaires were used to assess the research hypotheses at weeks 0, 4, and 12. Urinalysis was used to verify self-reported methamphetamine use at week 0. Urinalyses were used for those participants who reported abstinence from methamphetamine at weeks 4 and 12. Overall, 120 women were enrolled. Sixteen participants were lost to follow-up. Compared with the control group, the treatment group showed significant reductions in frequency of methamphetamine use (p < 0.001), severity of methamphetamine dependence (p < 0.001), and number of days of methamphetamine use (p < 0.001) at weeks 4 and 12. Significant improvements in readiness to change (p < 0.001), psychological well-being (p < 0.001), and social functioning (p = 0.001) were found in the treatment group at weeks 4 and 12. Nineteen urine specimens (31.66%) in the treatment group were negative for methamphetamine use at post-treatment and follow-up, while no change was found in the control group (0.00%). The study supported the efficacy of BCBT for methamphetamine use and associated harms.
机译:该研究评估了简要认知行为治疗(BCBT)对美沙酮维持妇女常规甲基苯丙胺使用的疗效。随机对照试验在四种美沙酮治疗服务中进行。符合条件的妇女被分配以获得BCBT或毒品教育。使用五个问卷评估0,4和12周的研究假设。尿液分析用于验证每周的自我报告的甲基苯丙胺。尿腹用于那些在第4周和12周内报告甲基苯丙胺戒断的参与者。总体而言,120名女性注册。十六位参与者失去了随访。与对照组相比,治疗组显示甲基苯丙胺使用频率(P <0.001),甲基苯丙胺依赖性(P <0.001)的严重程度,以及甲基苯丙胺使用的天数(P <0.001)的次数。在第4周和第12周,在治疗组中发现,在治疗组中发现了显着改善(P <0.001),心理福祉(P <0.001),以及社会功能(P = 0.001).99尿标本(31.66%)在治疗组中,在治疗后和随访中使用甲基苯丙胺使用负,而在对照组中没有发现任何变化(0.00%)。该研究支持BCBT对甲基苯丙胺使用和相关伤害的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号